-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

721.O2.6 721. Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Toxicities: Optimizing Outcomes in Adult Patients

Symposia: Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Toxicities Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Clinical trials, Clinical Practice (Health Services and Quality), Clinical Research, Health disparities research, Treatment Considerations, Real-world evidence, Technology and Procedures, Measurable Residual Disease
Saturday, December 7, 2024: 2:00 PM-3:30 PM
Room 6CF (San Diego Convention Center)
Moderators:
Kris Michael Mahadeo, MD, Duke University and Rusha Bhandari, MD, MS, City of Hope
Disclosures:
No relevant conflicts of interest to declare.

This session will explore novel preparative regimens and clinical strategies to improve supportive care and patient outcomes among Adult patients undergoing allogeneic transplantation.
2:00 PM

Filippo Milano, MD1,2, Brenda M. Sandmaier, MD3, Mary-Elizabeth M. Percival, MD4,5, Sarah M Mahan6*, Laura C Roberts6*, Raya Mawad, MD2,6, Anna B. Halpern, MD2,6, Madi Brunette6*, Cristina Maria Ghiuzeli, MD2,6, Jacob S. Appelbaum, MD, PhD4,7, Naveed Ali, MD, MBBS2,6 and Roland B. Walter, MD, PhD, MS6

1Fred Hutchinson Cancer Research Center, Seattle, WA
2University of Washington, Seattle, WA
3Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA
4Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA
5Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA
6Fred Hutchinson Cancer Center, Seattle, WA
7University of Washington School of Medicine, Seattle, WA

2:15 PM

Dan Feng*, Qingzhen Liu*, Qiaoling MA* and Erlie Jiang

State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences &Peking Union Medical College, Tianjin, China

2:30 PM

Charlotte FM Hughes, MD, FRACP, FRCPA1, Richard J. Lin, MD, PhD2,3, Sean M. Devlin, PhD4*, Brian C. Shaffer, MD, MS1,2, Ann A. Jakubowski, MD, PhD1,2, Vishwamber Talla1*, Amethyst Saldia, BS1*, Boglarka Gyurkocza, MD1,2, Esperanza B. Papadopoulos, MD1,2, Sergio A. Giralt, MD1,2, Elena Maryamchik, MD5*, Miguel-Angel Perales, MD1,2 and Roni Tamari, MD1,2

1Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, NY
2Department of Medicine, Weill Cornell Medical College, New York, NY
3Adult BMT Service; Cell Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY
4Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY
5Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY

2:45 PM

Jingtao Huang1*, Jing Zhou2*, Shixuan Zhang3*, Ruoxuan Zhang2*, Zengkai Pan4*, Luxiang Wang, MD, PhD4*, Chuanhe Jiang, MD, PhD4*, Jiayu Huang4*, Zilu Zhang, MD, PhD4*, Yanmin Zhao3*, Yang Cao5*, Jianmin Wang, MD, PhD6 and Xiaoxia Hu4*

1Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, Nati, Shanghai, China
2Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
3Bone Marrow Transplantation Center of The First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
4Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
5Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, San Diego, CA
6Changhai Hospital, Shanghai, China

3:00 PM

Francesco Zorutti, MD1*, Simonetta Saldi, MD2*, Loredana Ruggeri, MD, PhD3*, Valerio Viglione, MD1*, Christian Fulcheri4*, Rebecca Sembenico, MD1*, Matteo Caridi, MD1*, Anna Castaldo, MD1*, Antonella Mancusi, PhD1*, Claudio Zucchetti2*, Susanta Hui, PhD5*, Federico Camilli6*, Tiziana Zei3*, Roberta Iacucci Ostini3*, Enrico Karim Jardini3*, Eni Hoxha1*, Antonella Monaldi3*, Anthony S. Stein, MD7,8, Gianluca Ingrosso1*, Andrea Velardi, MD, PhD1*, Massimo Fabrizio Martelli, MD, PhD1*, Maria Paola Martelli, MD, PhD1,3*, Cynthia Aristei, MD2*, Alessandra Carotti, MD3* and Antonio Pierini, MD, PhD1*

1Department of Medicine and Surgery, Division of Hematology and Clinical Immunology, University of Perugia, Perugia, Italy
2Department of Medicine and Surgery, Radiation Oncology Section, University of Perugia, Perugia, Italy
3Department of Medicine and Surgery, Division of Hematology and Clinical Immunology, S. Maria della Misericordia Hospital, Perugia, Italy
4Department of Medicine and Surgery, Radiation Oncology Section, S. Maria della Misericordia Hospital, Perugia, Italy
5Radiation Oncology, City of Hope National Medical Center, Duarte, CA
6Department of Medicine and Surgery, Radiation Oncology Section, Santa Maria della Misericordia Hospital, Perugia, Italy
7Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
8City of Hope Cancer Center, Duarte, CA

3:15 PM

Xiaoqian Chen*, Wei Cui*, Qingya Cui*, Zheng Li, MD*, Sifan Chen*, Mengyun Li*, Xuekai Li*, Juan Chen*, Yan Yu*, Xin Zhang*, Depei Wu, MD, PhD and Xiaowen Tang*

National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China

*signifies non-member of ASH